Prescription drug · NDA
Fareston (Toremifene citrate) NDC 42747-327
Toremifene citrate 60 mg/1 · Tablet · Oral · Kyowa Kirin, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 42747-327-30 | 42747032730 | 30 TABLET in 1 BOTTLE (42747-327-30)Marketed from Jun 30, 1997 | |
| 42747-327-72 | 42747032772 | 7 TABLET in 1 BLISTER PACK (42747-327-72)Marketed from Jun 30, 1997 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Fareston
- Generic name (nonproprietary)
- toremifene citrate
- Active ingredients
- Toremifene citrate — 60 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Kyowa Kirin, Inc.NDC labeler code 42747
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 020497
- Marketing start
- Listing expires
- Other FDA classes
- Selective Estrogen Receptor Modulators (Mechanism)
- Identifiers
- Product ID 42747-327_11857fbe-6c5e-485e-b5d4-7f091a331928SPL ID 11857fbe-6c5e-485e-b5d4-7f091a331928SPL set ID 2cab8dd1-3a10-48e6-86ce-0e5275ed49e5RxCUI 152880, 313428UNII 2498Y783QT
- Pharmacologic class
- Estrogen Agonist/Antagonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N442747032730followed by a unit qualifier and the quantityPackage 42747-0327-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
FARESTON® is an estrogen agonist/antagonist indicated for the treatment of metastatic breast cancer in postmenopausal women with estrogen-receptor positive or unknown tumors. FARESTON® is an estrogen agonist/antagonist indicated for the treatment of metastatic breast cancer in postmenopausal women with estrogen-receptor positive or unknown tumors. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 42747-327
- What is NDC 42747-327?
- 42747-327 is the product NDC for Fareston (toremifene citrate), Toremifene citrate 60 mg/1 tablet, listed with the FDA by Kyowa Kirin, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Fareston (Toremifene citrate).
- What is the active ingredient?
- Toremifene citrate.
- Who is the labeler?
- Kyowa Kirin, Inc., NDC labeler code 42747. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Fareston?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.